Ucb, Inc.

Smyrna, GA Doing business as UCB Pharma, Inc.

UEI
F3N9Q9TY2BC9
CAGE
0S423
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
1950 Lake Park Dr SE, Smyrna, GA 30080, USA
Website
ucb.com
Founded
1928
Employees
5K-10K
Estimated annual revenue
$1B-$10B
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Ucb, Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Injectable drug for a veteran Contract · 36C24526F0346 Veterans Integrated Service Network 5 $31,041
Zilbrysq 32.4 MG Contract · 36C24526N0727 Veterans Integrated Service Network 5 $31,041
Zilbrysq 32.4 MG Contract · 36C24526N0666 Veterans Integrated Service Network 5 $31,041
Zilbrysq 32.4 MG Contract · 36C24526N0526 Veterans Integrated Service Network 5 $31,041
Zilbrysq 32.4 MG Contract · 36C24526N0378 Veterans Integrated Service Network 5 $31,041

About Ucb, Inc.

Ucb, Inc., doing business as UCB Pharma, Inc., is a global biopharmaceutical company based in Smyrna, Georgia, that manufactures and supplies injectable and oral neurological and immunological prescription medications to the Department of Veterans Affairs as a prime contractor on the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The company operates exclusively as a prime — 100% of its recent federal awards are prime contracts or indefinite delivery vehicles — competing on full-and-open, firm fixed-price vehicles with no set-aside designations.

UCB Pharma's federal footprint is narrowly concentrated in VA pharmaceutical procurement across a portfolio of $2.6 billion in combined potential value. The Department of Veterans Affairs accounts for 100% of awards: Veterans Integrated Service Network 12 anchors the dollars at $1.98 billion across four awards, while the VA's National Acquisition Center holds $613.2 million across three awards (the two largest single vehicles). VISN 5 and VISN 20 account for the remaining awards but represent only $833 thousand in total obligated spend across the portfolio. All awards operate under the Pharmaceuticals and Drugs FSS-61-IB schedule with pre-negotiated pricing; place of performance is Pittsburgh, Pennsylvania, with product distribution to VA facilities nationwide.

UCB Pharma's primary vehicle is a $1.11 billion Federal Supply Schedule contract awarded September 15, 2025, through September 14, 2030, covering Zilbrysq (the company's flagship injectable neurological treatment), Fintepla, Kygevvi, Cimzia, Nayzilam, Neupro, Vimpat, Briviact, and Keppra. A single-award Blanket Purchase Agreement worth $3.84 million was awarded October 31, 2025, through October 30, 2027, also covering Fintepla and Zilbrysq. Recent delivery orders under these vehicles include five orders from VISN 5 (March through August 2026) for Zilbrysq 32.4 mg at $31,040.96 each, a $371.2 thousand order from VISN 20 in October 2025 for Zilbrysq with 2026 price adjustment, and a $214.2 thousand bulk Zilbrysq order from VISN 20 in October 2024. Activity has grown from one award in 2022 to five in 2026, though this trajectory reflects the award of the large FSS-61-IB vehicle in September 2025 and the BPA in October 2025; one award (the $371 thousand VISN 20 BPA delivery order) reaches ultimate completion within the next twenty-four months and faces recompete exposure. The vendor holds no subcontract relationships in the source data.

Contract vehicles

Quick answers

What is Ucb, Inc.'s UEI?

Ucb, Inc.'s Unique Entity ID (UEI) in SAM.gov is F3N9Q9TY2BC9.

What is Ucb, Inc.'s CAGE code?

Ucb, Inc.'s CAGE code is 0S423.

What is Ucb, Inc.'s primary NAICS code?

Ucb, Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Where is Ucb, Inc. located?

Ucb, Inc.'s physical address in SAM.gov is 1950 Lake Park Dr SE, Smyrna, GA 30080, USA.

Is Ucb, Inc. registered in SAM.gov?

Yes. Ucb, Inc.'s SAM.gov registration is active through May 11, 2027.

Which contract vehicles does Ucb, Inc. hold?

Ucb, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.

What is Ucb, Inc.'s most recent federal award?

Ucb, Inc.'s most recent federal contract award is Injectable drug for a veteran (36C24526F0346), from Veterans Integrated Service Network 5, on August 6, 2026.

On GovTribe

See Ucb, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors